• Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016
Monday Morning
Skip to content
  • Home
  • About
  • Contact
  • Steve Walker
  • Subscriptions
    • Sample MondayMorning Newsletter January 11, 2016

Tag Archives: David Daven

Largely ignored by Trump, Puerto Rico’s hurricane disaster slams island’s pharmaceutical industry; US mainland’s access to crucial medicines could take a big hit.

Steve Walker    October 11, 2017 November 6, 2017    No Comments on Largely ignored by Trump, Puerto Rico’s hurricane disaster slams island’s pharmaceutical industry; US mainland’s access to crucial medicines could take a big hit.

The News: Unknown to the vast majority of mainland US citizens, a nightmare scenario stemming from “supply chain instability” is unfolding right now in Puerto Rico. Brought to light by… Read more »

Government, Pharmaceuticals    AbbVie Inc., American Prospect, Amgen Inc., AstraZeneca PLC, Crestor, David Daven, Eli Lilly & Co., Heather Digby Parton, Humira, Hurricane Maria, Ingrid Torjesen, Johnson & Johnson, Pfizer Inc., PhRMA, President Donald Trump, Puerto Rico, Salon, Scott Gottlieb, Section 936 of the Internal Revenue Code, The Pharmaceutical Journal, U.S. Food and Drug Administration

Search The Site

Follow @MonMorningNews

Twitter

Tweets by MonMorningNews
Follow me on Blogarama

Facebook

Search The Site

More MondayMorning

  • Recent Posts
  • Most Commented
  • Most Viewed
  • Reducing salt consumption may protect against Alzheimer’s. Considering the stakes, start now.
  • US stock market has a subdued Thanksgiving week, but a slew of healthcare companies rocketed higher.
  • More Chinese medical companies choosing New York over Shanghai, Hong Kong for IPOs; but not always.
  • Health-sector IPO market cools off for Veterans Day breather; but pre-Thanksgiving deals ready to rock.
    • Insys trial opens with tale of sales rep giving lap dance to doctor for fentanyl prescriptions. News organizations seize upon...
    • Voyager Therapeutics signs another neurodegenerative disease deal with AbbVie that screams “Buy this small cap now.”
    • Little known Czech biotech’s cell therapy greatly increases survival in ovarian cancer. Sotio’s potential breakthrough and another pipeline cancer candidate...
    • Powered only by heart muscle, experimental pacemaker doesn’t need new batteries. Goodbye (hopefully) to battery-replacement surgery; but hello international patent...
    Copyright 2018
    Ribosome by GalussoThemes.com
    Powered by WordPress